Pilot Projects

The COBRE Pilot Project Research Program provides up to $75,000 direct costs for one year’s support of basic or translational research projects that align with the COBRE focus. In addition, funded pilot investigators will have access to all of the COBRE’s core laboratories and facilities free of charge. Applicants are also advised to take advantage of the expertise available within other COBRE project teams and interact/collaborate with them. Funded COBRE pilot investigators will be required to participate in local, regional, and national COBRE and IDeA (Institutional Development Award) meetings, to give periodic progress reports when requested, and to submit a comprehensive final written report detailing the studies performed and the findings. If you have any questions on the nature or scope of the proposed project, please contact Dr. Martin Hauer-Jensen, COBRE Principal Investigator (

Funded Pilot Projects:

  • miRNA Biomarkers of Cisplatin Nephrotoxicity in Genetically Sensitive Subjects.  PROJECT LEADER:  Alison Hege Harrill, Ph.D., Department of Environmental and Occupational Health, College of Medicine.
  • Effects of Methotrexate and Cytosine arabinoside on Cognition. PROJECT LEADER:  Antino Recio Allen, Ph.D., Department of Physiology and Biophysics, College of Medicine.
  • Prevention of Doxorubicin Cardiomyopathy in Cancer Treatment.PROJECT LEADER:  Sharda Prakash Singh, Ph.D., Department of Toxicology/Pharm, College of Medicine.
  • Kinase Dysregulation and Impact on Radiotherapy Resistance: Development of Molecular Tools to Normalize Kinase Signaling. PROJECT LEADER: Brendan Frett, Ph.D., Department of Pharmaceutical Sciences, The College of Pharmacy.
  • Photobiomodulation of Neuronal Mitochondria for the Treatment of Radiation-Induced Cognitive Dysfunction, PROJECT LEADER: Analiz Rodriguez, M.D., Ph.D., Department of Neurosurgery.